CRIS Current Research Information System

GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.572
EU - Europa 5.689
AS - Asia 2.426
AF - Africa 292
SA - Sud America 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.562
IT - Italia 1.517
GB - Regno Unito 1.384
CN - Cina 896
SE - Svezia 693
DE - Germania 663
SG - Singapore 645
VN - Vietnam 510
UA - Ucraina 358
RU - Federazione Russa 290
IN - India 248
IE - Irlanda 213
FR - Francia 200
EE - Estonia 112
ZA - Sudafrica 102
TG - Togo 88
BG - Bulgaria 61
JO - Giordania 57
FI - Finlandia 50
NG - Nigeria 45
CH - Svizzera 33
CI - Costa d'Avorio 31
BE - Belgio 30
IR - Iran 23
NL - Olanda 23
SC - Seychelles 23
AT - Austria 17
JP - Giappone 16
GR - Grecia 11
AU - Australia 9
LB - Libano 9
CA - Canada 8
ES - Italia 7
EU - Europa 7
PL - Polonia 7
HK - Hong Kong 6
CL - Cile 5
BR - Brasile 4
KR - Corea 4
PT - Portogallo 4
RO - Romania 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
EG - Egitto 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 15.006
Salva come PNG Salva come JPEG
Città #
Southend 1.242
Fairfield 839
Singapore 575
Ashburn 507
Chandler 483
Woodbridge 471
Wilmington 434
Houston 406
Seattle 401
Santa Clara 307
Cambridge 297
Dong Ket 292
Princeton 292
Ann Arbor 264
Jacksonville 225
Dublin 212
Boardman 161
Padova 146
Nanjing 144
Westminster 133
Bologna 112
Milan 108
Berlin 98
Lomé 88
Rome 83
Bremen 77
Jinan 72
New York 70
Shenyang 70
Saint Petersburg 62
Sofia 60
Beijing 58
Amman 57
Turin 56
Helsinki 48
Changsha 46
Abeokuta 45
Medford 45
San Diego 45
Hebei 40
Mülheim 40
Nanchang 39
Florence 38
Zhengzhou 38
Dearborn 33
Abidjan 31
Jiaxing 30
Los Angeles 29
Naples 29
Verona 29
Brussels 28
Guangzhou 26
Tianjin 26
Mahé 23
Bern 22
Redwood City 21
Ningbo 19
Des Moines 18
Shanghai 18
Bari 17
Falls Church 17
Olalla 17
Yubileyny 17
Taizhou 16
Hangzhou 15
Tokyo 15
Catania 14
Haikou 13
Kunming 13
Taiyuan 13
Vienna 13
Dallas 12
Norwalk 12
Parma 12
Redmond 12
Cagliari 11
Kuban 11
London 11
Todi 11
Ardabil 10
Como 10
Monmouth Junction 10
San Venanzo 10
Venezia 10
Bühl 9
Palermo 9
Trento 9
Arquata Scrivia 7
Bolzano 7
Duncan 7
Groningen 7
Lanzhou 7
Leawood 7
Nuremberg 7
Pisa 7
Rho 7
San Genesio Ed Uniti 7
Xi'an 7
Brescia 6
Casamarciano 6
Totale 10.146
Salva come PNG Salva come JPEG
Nome #
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 1.046
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 233
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 224
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 182
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 175
Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: A meta-analysis 171
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 158
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 156
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 153
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 152
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 152
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 146
Cardiac transplantation from a carbon monoxide intoxicated donor. 143
Age and heart transplantation: results from a heart failure management unit. 142
Electrocardiographic remodeling during cardiac resynchronization therapy 138
Post-operative pleural effusion in a heart transplant recipient: A singlecase study of physiotherapy treatment 135
Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. 133
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 133
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 132
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 132
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 131
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 131
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 128
Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes 127
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 127
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 127
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 125
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 125
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 125
Comparative effectiveness of disease-modifying-drugs in elderly patients after incident hospitalization for heart failure 125
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 125
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 123
Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets 123
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 122
Role of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation in Early Graft Failure After Cardiac Transplantation 121
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 120
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 119
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 118
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 116
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 116
Cardiac resynchronization by pacing: an electrical treatment of heart failure 116
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 115
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 115
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 114
Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study 114
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 113
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 113
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 113
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 112
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 111
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 111
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 111
Role of severe functional mitral regurgitation in predicting electrical remodeling in idiopathic dilated cardiomyopathy. 111
Implantation of cardioverter-defibrillator: Effects on shoulder function. 110
Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. 109
Left Atrial Size is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets: Results from a Large International Multicenter Study. 109
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 108
Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it? 108
Management of asymptomatic mitral regurgitation. 107
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 107
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 106
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 106
Heart transplantation in hypertrophic cardiomyopathy. 105
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 105
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 105
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 104
RotaFlow and CentriMag Extracorporeal Membrane Oxygenation Support Systems as Treatment Strategies for Refractory Cardiogenic Shock 104
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 104
Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study 103
Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era 103
Prevalence of substance-related disorders in heart transplantation candidates 103
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 103
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 102
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 102
Quantitation of mitral regurgitation 101
Intraoperative rupture of the donor aorta during heart transplantation: surgical management with a Bentall-de Bono procedure. 101
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 100
Efficacia del trattamento a lungo termine con statine nel paziente trapiantato di cuore. 100
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 100
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 99
First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation 99
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 99
null 99
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 98
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 98
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 97
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 97
Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A Multicenter Long-term International Study 96
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 95
Outcomes in mitral regurgitation due to flail leaflets a multicenter European study. 95
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 94
Atrial fibrillation, vascular phenotype, APOE genotype and Alzheimer's Disease: a perspective cohort study 94
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 94
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 93
Mechanical circulatory support with centrifugal pump as bridge to heart transplantation. 92
EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 92
The risk of right ventricular failure with current continuous-flow left ventricular assist devices 92
Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: A multicenter analysis 92
Sicurezza dell'utilizzo delle statine nel paziente trapiantato di cuore:16 anni di esperienza clinica. 91
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 91
Totale 12.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.688 0 0 0 0 0 0 0 499 536 251 155 247
2020/20211.883 408 138 65 83 53 70 24 99 154 104 83 602
2021/20222.521 205 113 169 316 225 139 59 158 110 191 430 406
2022/20232.649 259 362 157 341 205 208 78 136 458 101 212 132
2023/2024819 65 122 42 96 58 167 38 34 31 67 55 44
2024/20251.872 153 435 235 220 506 137 156 30 0 0 0 0
Totale 15.320